279 results on '"Zhang, Wanguang"'
Search Results
2. USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma
3. Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies
4. Defining Global Benchmarks for Laparoscopic Right Posterior Sectionectomy/H67: An International Multicenter Study
5. Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study
6. Progress of Research on Tumor Extracellular Matrix and Discoidin Domain Receptor 1
7. Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments
8. Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multicenter Study
9. Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis
10. Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy
11. Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study
12. Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis
13. Impact of liver cirrhosis, the severity of cirrhosis, and portal hypertension on the outcomes of minimally invasive left lateral sectionectomies for primary liver malignancies
14. Propensity-score Matched and Coarsened-exact Matched Analysis Comparing Robotic and Laparoscopic Major Hepatectomies: An International Multicenter Study of 4822 Cases
15. Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy
16. Impact of body mass index on perioperative outcomes of laparoscopic major hepatectomies
17. Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: A pilot study (with video)
18. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway
19. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
20. Immune checkpoint inhibitor‑associated diabetes mellitus in patients with HCC: Report of three cases and literature review
21. Ex vivo resection, vessel reconstruction and liver autotransplantation for cholangiocarcinoma: A report of two cases
22. DEAD‐Box Helicase 17 exacerbates non‐alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages
23. Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments
24. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
25. Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis
26. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+T cell-mediated antitumour immunity and improves anti-PD-1 efficacy
27. Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma
28. Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis
29. Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study
30. Impact of liver cirrhosis, the severity of cirrhosis, and portal hypertension on the outcomes of minimally invasive left lateral sectionectomies for primary liver malignancies
31. Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study
32. Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy
33. Impact of body mass index on perioperative outcomes of laparoscopic major hepatectomies
34. Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma
35. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+T cell-mediated antitumour immunity and improves anti-PD-1 efficacy
36. Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
37. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization
38. Reliable reconstruction of the complex high-location bile duct injury: a novel hepaticojejunostomy
39. Association of habitual sleep duration and its trajectory with the risk of cancer according to sex and body mass index in a population‐based cohort.
40. Perioperative outcomes of robot-assisted versus laparoscopic liver resection for cavernous hemangioma: a propensity score matching study
41. Impact of liver cirrhosis, the severity of cirrhosis, and portal hypertension on the outcomes of minimally invasive left lateral sectionectomies for primary liver malignancies
42. Impact of body mass index on perioperative outcomes of laparoscopic major hepatectomies
43. Infrahepatic inferior vena cava clamping with Pringle maneuvers for laparoscopic extracapsular enucleation of giant liver hemangiomas
44. Surgical treatment of hepato-pancreato-biliary disease in China: the Tongji experience
45. Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: a propensity score matching analysis.
46. Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
47. Collagen Ⅰ-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression.
48. Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: More details, more significance
49. Is Alpps Still Appropriate for Large or Locally Advanced Hepatocellular Carcinoma in an Era of Targeted Agents and Immunotherapy? – a Case Series
50. Nitrate removal under different ecological remediation measures in Taihu Lake: a 15 N mass-balance approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.